Lv4
578 积分 2023-07-26 加入
A phase ib trial of assessing the safety and preliminary efficacy of a combination therapy of geptanolimab (GB 226) plus fruquintinib in patients with metastatic colorectal cancer (mCRC)
30天前
已关闭
Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial
30天前
已完结
Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements
1个月前
已完结
Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases
1个月前
已完结
PD-1 blockade in solid tumors with defects in polymerase epsilon
1个月前
已完结
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
1个月前
已完结
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity
1个月前
已完结
POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
1个月前
已完结
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
1个月前
已完结
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
1个月前
已完结
皖公网安备34019202002308
